aTyr Pharma, Inc.ATYRNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank97
3Y CAGR+2.0%
5Y CAGR+8.4%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
+2.0%/yr
vs +30.4%/yr prior
5Y CAGR
+8.4%/yr
Recent deceleration
Acceleration
-28.4pp
Decelerating
Percentile
P97
Near historical high
vs 5Y Ago
1.5x
Solid growth
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 46.15% |
| Q3 2025 | -18.18% |
| Q2 2025 | -29.41% |
| Q1 2025 | 5.56% |
| Q4 2024 | 21.74% |
| Q3 2024 | 0.00% |
| Q2 2024 | 0.00% |
| Q1 2024 | 8.00% |
| Q4 2023 | -25.00% |
| Q3 2023 | 9.09% |
| Q2 2023 | 24.14% |
| Q1 2023 | -11.54% |
| Q4 2022 | 43.48% |
| Q3 2022 | -4.55% |
| Q2 2022 | 0.00% |
| Q1 2022 | -41.94% |
| Q4 2021 | 26.19% |
| Q3 2021 | 34.38% |
| Q2 2021 | -25.49% |
| Q1 2021 | -8.51% |
| Q4 2020 | 30.88% |
| Q3 2020 | 1.45% |
| Q2 2020 | -376.00% |
| Q1 2020 | 116.23% |
| Q4 2019 | -4.76% |
| Q3 2019 | 18.33% |
| Q2 2019 | 29.13% |
| Q1 2019 | 13.01% |
| Q4 2018 | 12.31% |
| Q3 2018 | 31.76% |
| Q2 2018 | 2.59% |
| Q1 2018 | 7.22% |
| Q4 2017 | 11.04% |
| Q3 2017 | 14.99% |
| Q2 2017 | 9.73% |
| Q1 2017 | -6.60% |
| Q4 2016 | 9.07% |
| Q3 2016 | 10.33% |
| Q2 2016 | 4.51% |
| Q1 2016 | 2.56% |